UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042547
Receipt number R000048560
Scientific Title The efficacy and safety of treatment with zoledronic acid in patients and the influence of patient characteristics.
Date of disclosure of the study information 2020/11/25
Last modified on 2021/05/10 10:43:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy and safety of treatment with zoledronic acid in patients and the influence of patient characteristics.

Acronym

The efficacy and safety of treatment with zoledronic acid in patients and the influence of patient characteristics.

Scientific Title

The efficacy and safety of treatment with zoledronic acid in patients and the influence of patient characteristics.

Scientific Title:Acronym

The efficacy and safety of treatment with zoledronic acid in patients and the influence of patient characteristics.

Region

Japan


Condition

Condition

Primary osteoporosis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy and safety and the influence of patient characteristics of treatment with zoledronic acid.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

The rate of change in the lumbar spine BMD.

Key secondary outcomes

The rate of change in the femoral neck BMD, the changes in type I procollagen N-terminal propeptide (P1NP), tartrate-resistant acid phosphatase-5b (TRACP-5b), VAS score of back pain, Japanese Osteoporosis Quality of Life Questionnaire (JOQOL).


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

55 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Patients who met the required inclusion criteria were enrolled in this study.

1. Patients with osteoporosis starting the treatment using ZOL from November 2016 to June 2019 at Koenji Orthopedics Clinic
2. Patients 55 years of age or older
3. Postmenopausal women who were diagnosed with primary osteoporosis

Key exclusion criteria

1. Patients with a metabolic bone disease other than osteoporosis
2. Patients with a history of hypersensitivity to the study drug or BP
3. Patients who have severe renal impairment (creatinine clearance < 35 mL/min) at the start
4. Patients who are dehydrated (high fever, severe diarrhea and vomiting, etc.) at the start
5. Patients who have hypocalcemia at the start
6. Patients whom the physicians judged to be unsuitable because of idiosyncratic complications and markedly different background

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Fumitoshi
Middle name
Last name Omura

Organization

Koenji Orthopedics Clinic

Division name

N/A

Zip code

166-0003

Address

4-29-2 Koenji-minami, Suginami-ku, Tokyo, Japan.

TEL

03-5377-3291

Email

oomura-f@rg7.so-net.ne.jp


Public contact

Name of contact person

1st name Fumitoshi
Middle name
Last name Omura

Organization

Koenji Orthopedics Clinic

Division name

N/A

Zip code

166-0003

Address

4-29-2 Koenji-minami, Suginami-ku, Tokyo, Japan.

TEL

03-5377-3291

Homepage URL


Email

oomura-f@rg7.so-net.ne.jp


Sponsor or person

Institute

Koenji Orthopedics Clinic

Institute

Department

Personal name



Funding Source

Organization

Asahi Kasei Pharma Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Medical Association Ethical Review Board

Address

2-28-8 Honkomagome, Bunkyo-ku, Tokyo,Japan

Tel

03-5319-3781

Email

rinri@jmacct.med.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

高円寺整形外科(東京都)


Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 25 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.ecronicon.com/ecor/ECOR-12-00747.php

Number of participants that the trial has enrolled

88

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 01 Month 30 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 03 Month 12 Day

Date of IRB

2020 Year 04 Month 23 Day

Anticipated trial start date

2020 Year 04 Month 24 Day

Last follow-up date

2020 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2020 Year 06 Month 09 Day

Date analysis concluded

2020 Year 07 Month 14 Day


Other

Other related information

Retrospective study


Management information

Registered date

2020 Year 11 Month 25 Day

Last modified on

2021 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048560


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name